Clinical Trial Update: A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating mycophenolate mofetil (CellCept) with tacrolimus and corticosteroids in kidney transplant patients has completed, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)
• Corticosteroids (corticosteroids)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Kidney Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2014-08-04